Aprotinin

Robbins P, Forrest M, Von Kier S, Royston D. "[Thrombelastograph®] evaluation of the interaction between ReoPro (C7E3 FAB) and Hemostatic Drugs." Anesthesiology. Sept. 1997. V87, No3A.

Chalkiadis GA, Gibbs NM. "The Effect of Aprotinin on [Thrombelastograph® Analysis] in vitro." Anaesth Instens Care. 1996;24:552-554.

De Hert SG, Farooqi NU, Delrue GL, Broecke PWT, Vermeyen KM, Adriaensen HF. "Dose dependent effect of aprotinin on rate of clot formation." European Journal of Anesthesiology. 1996,13,463-467.

Tuman KJ, McCarthy RJ, Patel RB, Ivankovich AD, "Quantification of Aprotinin Reversal of Severe Fibrinolysis in Dogs Using [Thrombelastograph® Analysis]". Anesth Analog. 1993:76:S1-S476.

Royston D. "High-Dose Aprotinin Therapy: A Review of the First Five Years Experience." Journal of Cardiothoracic and Vascular Anesthesia. February 1992:V6, No 1, pp76-100.

Royston D. "Aprotinin Prevents Bleeding and Has Effects on Platelets and Fibrinolysis." Journal of Cardiothoracic and Vascular Anesthesia. December 1991: V5, No. 6, Suppl 1, pp 18-23.

Mallett S, Rolles K, Cox D, Burroughs A, Hunt B. "Intraoperative Use of Aprotinin (Trasylol) in Orthotopic Liver Transplantation." Transplantation Proceedings. (June), 1991:V23, No.3:pp 1931-1932.

Kang Y, De Wolf AM, Aggarwal S, Campbell E, Martin LK. "In Vitro Study of the Effects of Aprotinin on Coagulation During Orthotopic Liver Transplantation." Transplantation Proceedings. (June), 1991:V23, No.3. pp 1934-35.